Please select a Capability in order to start your service request.
Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safetyApr 3, 2017
BOSTON, M.A., April 3, 2017 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its quality improvement program, BD “Power in Prevention” at the Association of periOperative Registered Nurses (AORN) annual conference being held in Boston from April 1 – 5.
The BD Power in Prevention program leverages critical insights from the company’s Focus on Quality Care program, which since its inauguration in 2012, has conducted more than 20,000 observations at more than 800 facilities in the field of infection prevention. The newly established BD Power in Prevention program builds on BD’s heritage of minimizing the risks of infection to help standardize processes and promote high-quality outcomes for optimal patient care. Led by a team of clinicians and product experts, this unique program uses a comprehensive quantitative process to identify potential risks for infections and provides evidence-based infection control strategies for specific areas of quality improvement in skin preparation, hair removal, surgical instrument care and handling and hand-hygiene. Facilities participating in the BD Power in Prevention program recognized tangible results includingi a 50 percent increase in compliance to manufacturers’ directions for skin prep as well as a 20 percent reduction in practice variability.
“We are grateful for the BD Power in Prevention program because it gave us the necessary tools and resources to have a formal quality improvement initiative at our clinic,” said Cheryl Bennett, vascular OR project lead, Carilion Clinic. “We have been involved in many of these types of programs before but this is one of the few where we can see a difference in our nurses – they feel empowered to make a difference.”
BD at AORN
The BD commitment to advancing health and quality care initiatives will be highlighted in two onsite opportunities for conference attendees.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.